Applied Therapeutics Valuation
| APLT Stock | USD 0.46 0.01 2.13% |
Applied Therapeutics is overvalued. Applied Therapeutics shows a prevailing Real Value of $0.38 per share. The current price of the firm is $0.46. Our model approximates the value of Applied Therapeutics from analyzing the firm fundamentals such as Operating Margin of (410.31) %, shares outstanding of 141.58 M, and Return On Equity of -0.84 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Applied Therapeutics' valuation include:
Price Book 1.7834 | Enterprise Value | Enterprise Value Ebitda (9.71) | Price Sales 246.7696 | Enterprise Value Revenue 65.4028 |
Overvalued
Today
Please note that Applied Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Applied Therapeutics is based on 3 months time horizon. Increasing Applied Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Applied Therapeutics' intrinsic value may or may not be the same as its current market price of 0.46, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.46 | Real 0.38 | Target 5.63 | Hype 0.46 | Naive 0.49 |
The intrinsic value of Applied Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Applied Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Applied Therapeutics helps investors to forecast how Applied stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Applied Therapeutics more accurately as focusing exclusively on Applied Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Applied Therapeutics' intrinsic value based on its ongoing forecasts of Applied Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Applied Therapeutics' closest peers.
Applied Therapeutics Cash |
|
Applied Valuation Trend
Applied Therapeutics' real value is important for investors to make better decisions and a more accurate overall view of Applied Therapeutics' financial worth over time. Using both Applied Therapeutics' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Applied Therapeutics Total Value Analysis
Applied Therapeutics is presently expected to have valuation of 17.33 M with market capitalization of 65.39 M, debt of 2.79 M, and cash on hands of 67.72 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Applied Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.33 M | 65.39 M | 2.79 M | 67.72 M |
Applied Therapeutics Investor Information
About 83.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied Therapeutics recorded a loss per share of 0.24. The entity had not issued any dividends in recent years. Based on the key indicators related to Applied Therapeutics' liquidity, profitability, solvency, and operating efficiency, Applied Therapeutics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in August.Applied Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Applied Therapeutics has an asset utilization ratio of 0.52 percent. This implies that the Company is making $0.005249 for each dollar of assets. An increasing asset utilization means that Applied Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Applied Therapeutics Ownership Allocation
Applied Therapeutics holds a total of 141.58 Million outstanding shares. The majority of Applied Therapeutics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Applied Therapeutics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Applied Therapeutics. Please pay attention to any change in the institutional holdings of Applied Therapeutics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Applied Therapeutics Profitability Analysis
The company reported the previous year's revenue of 455 K. Net Loss for the year was (105.62 M) with loss before overhead, payroll, taxes, and interest of (44.1 M).About Applied Therapeutics Valuation
The stock valuation mechanism determines Applied Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Applied Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Applied Therapeutics. We calculate exposure to Applied Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Applied Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 30 K | 28.5 K | |
| Pretax Profit Margin | (232.14) | (243.75) | |
| Operating Profit Margin | (229.23) | (240.69) | |
| Net Loss | (232.14) | (243.75) | |
| Gross Profit Margin | 0.07 | 0.06 |
Applied Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Applied Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 139.5 M |
Applied Therapeutics Current Valuation Indicators
Applied Therapeutics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Applied Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Applied Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Applied Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Applied Therapeutics' worth.Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.